98 related articles for article (PubMed ID: 7216154)
1. Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection.
Huges-Law G; de Gast GC; Houwen B; The TH; Tegzess AM; van der Hem GK
Hepatogastroenterology; 1981 Apr; 28(2):93-5. PubMed ID: 7216154
[TBL] [Abstract][Full Text] [Related]
2. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
4. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
6. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in acute and chronic hepatitis.
Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
[TBL] [Abstract][Full Text] [Related]
9. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
Sprengers D; van der Molen RG; Kusters JG; De Man RA; Niesters HG; Schalm SW; Janssen HL
J Hepatol; 2006 Aug; 45(2):182-9. PubMed ID: 16516331
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection in hemodialysis: recent discoveries.
Fabrizi F; Lunghi G; Martin P
J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection in chronic hemodialysis patients in Korea.
Gwak GY; Huh W; Lee DH; Min BH; Koh KC; Kim JJ; Oh HY
Hepatogastroenterology; 2008; 55(86-87):1721-4. PubMed ID: 19102377
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.
Nouri-Aria KT; Alexander GJ; Portmann B; Vergani D; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Apr; 64(1):50-8. PubMed ID: 2942323
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.
Chisari FV; Bieber MS; Josepho CA; Xavier C; Anderson DS
J Immunol; 1981 Jan; 126(1):45-9. PubMed ID: 6450241
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
Paul S; Tabassum S; Islam MN
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
[TBL] [Abstract][Full Text] [Related]
15. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection in allogeneic bone marrow transplantation.
Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus markers among family contacts and medical personnel of 239 hemodialysis patients.
Gahl GM; Vogl E; Kraft D; Hess G; Arnold W
Clin Nephrol; 1980 Jul; 14(1):8-12. PubMed ID: 7408256
[TBL] [Abstract][Full Text] [Related]
18. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
[TBL] [Abstract][Full Text] [Related]
19. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
[TBL] [Abstract][Full Text] [Related]
20. [Induction of specific cytotoxic T lymphocyte response against hepatitis B virus by hepatitis B virus S gene-modified dendritic cells].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):108-10. PubMed ID: 17653306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
